Cargando…
Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers
Triple receptor-negative breast cancers (TNBCs) generally have poor prognoses because of the loss of therapeutic targets. As lysophosphatidic acid (LPA) receptor signaling has been shown to affect breast cancer initiation and progression, we try to evaluate the potential roles of LPA receptors in TN...
Autores principales: | Sun, Kai, Cai, Hui, Duan, Xiaoyi, Yang, Ya, Li, Min, Qu, Jingkun, Zhang, Xu, Wang, Jiansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522273/ https://www.ncbi.nlm.nih.gov/pubmed/25209561 http://dx.doi.org/10.1007/s10238-014-0306-5 |
Ejemplares similares
-
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017) -
Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer
por: Hirata, Naoya, et al.
Publicado: (2022) -
Role of Aberrantly Activated Lysophosphatidic Acid Receptor 1 Signaling Mediated Inflammation in Renal Aging
por: Jin, Yongjie, et al.
Publicado: (2021) -
The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015) -
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)